Aurora Cannabis Q3 EPS Forecast Lifted by Atb Cap Markets

Aurora Cannabis Inc. (NASDAQ:ACB) – Equities researchers at Atb Cap Markets upped their Q3 2025 earnings per share (EPS) estimates for shares of Aurora Cannabis in a research report issued on Wednesday, November 6th. Atb Cap Markets analyst F. Gomes now anticipates that the company will earn ($0.09) per share for the quarter, up from their prior forecast of ($0.16). The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.02) per share. Atb Cap Markets also issued estimates for Aurora Cannabis’ Q4 2025 earnings at ($0.06) EPS, FY2025 earnings at ($0.02) EPS, FY2026 earnings at ($0.03) EPS, FY2027 earnings at ($0.05) EPS, FY2028 earnings at $0.18 EPS and FY2029 earnings at $0.84 EPS.

Aurora Cannabis Price Performance

ACB opened at $4.73 on Monday. The firm has a market capitalization of $259.39 million, a PE ratio of -6.22 and a beta of 1.87. The business’s 50-day moving average is $5.59 and its two-hundred day moving average is $5.94. Aurora Cannabis has a 1 year low of $2.84 and a 1 year high of $9.35. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.83 and a quick ratio of 2.03.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Concurrent Investment Advisors LLC purchased a new position in Aurora Cannabis during the 1st quarter worth $90,000. Headlands Technologies LLC acquired a new stake in Aurora Cannabis in the first quarter worth about $166,000. Virtu Financial LLC purchased a new stake in shares of Aurora Cannabis during the first quarter worth about $727,000. Cetera Advisors LLC acquired a new position in shares of Aurora Cannabis during the first quarter valued at about $59,000. Finally, Baader Bank Aktiengesellschaft boosted its stake in Aurora Cannabis by 121.1% in the 2nd quarter. Baader Bank Aktiengesellschaft now owns 22,789 shares of the company’s stock worth $100,000 after purchasing an additional 12,481 shares in the last quarter. Hedge funds and other institutional investors own 47.63% of the company’s stock.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.